leisure time
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: Asbestos, a deadly carcinogen, banned by EPA
Next article: Asbestos, a deadly carcinogen, banned by EPA
focus
Wikipedia
-
Abridge raises $150m as clinical notes automation market heats up
2025-09-28 01:26 -
Surprise medical billing ban raises prices elsewhere
2025-09-28 01:19 -
Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech
2025-09-28 00:04 -
Asbestos, a deadly carcinogen, banned by EPA
2025-09-27 23:43 -
Gene editing the human germline: What are the risks?
2025-09-27 23:33 -
Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma
2025-09-27 23:20